Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Interest & Investment Income (2023 - 2026)

Adagio Medical Holdings has reported Interest & Investment Income over the past 4 years, most recently at $107000.0 for Q1 2026.

  • Quarterly Interest & Investment Income fell 34.76% to $107000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $420000.0 through Mar 2026, up 26.13% year-over-year, with the annual reading at $477000.0 for FY2025, 13.57% up from the prior year.
  • Interest & Investment Income was $107000.0 for Q1 2026 at Adagio Medical Holdings, down from $132000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $166000.0 in Q3 2024 and troughed at $1000.0 in Q4 2023.
  • The 4-year median for Interest & Investment Income is $90500.0 (2025), against an average of $75600.0.
  • The largest YoY upside for Interest & Investment Income was 16300.0% in 2025 against a maximum downside of 52.41% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $1000.0 in 2023, then soared by 16500.0% to $166000.0 in 2024, then decreased by 20.48% to $132000.0 in 2025, then decreased by 18.94% to $107000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Interest & Investment Income are $107000.0 (Q1 2026), $132000.0 (Q4 2025), and $79000.0 (Q3 2025).